Search Results - "Izu‐Belloso, R."

Treatment of moderate‐to‐severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series by Armario‐Hita, J.C., Pereyra‐Rodriguez, J., Silvestre, J.F., Ruiz‐Villaverde, R., Valero, A., Izu‐Belloso, R., Jáuregui‐Presa, I., Curto‐Barredo, L., Figueras‐Nart, I., Herranz‐Pinto, P., Herraez‐Herrera, L., Ortiz‐de‐Frutos, F.J., Martinez‐Pilar, L., Sastre, J., Serra‐Baldrich, E.

Get full text

Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real‐life clinical practice by Butrón‐Bris, B., Llamas‐Velasco, M., Ovejero‐Benito, M. C., Santos‐Juanes, J., Martínez‐López, A., Ruiz‐Villaverde, R., Roustan, G., Baniandrés, O., Izu‐Belloso, R., Cueva, P., Sahuquillo‐Torralba, A., Gónzalez‐Quesada, A., Vilarrasa‐Rull, E., Pujol‐Montcusí, J., García‐Martínez, J., Navares, M., Palomar‐Moreno, I., Novalbos, J., Abad‐Santos, F., Daudén, E., Fuente, H.

“…Detecting the association of genetic variants to the response of biological therapy represents an important advance in developing a personalized therapy. The…”
Get full text

Family Planning Concerns Among Women With Psoriasis: A Descriptive, Cross-Sectional, Multicenter Study by Jiménez Gómez, N, González-Cantero, Á, Ruiz-Villaverde, R, Llamas-Velasco, M, de la Cueva Dobao, P, Rivera Díaz, R, Martínez Lorenzo, E, Alonso Pacheco, M L, Baniandrés Rodríguez, O, Mollet Sánchez, J, Pitarch Bort, G, Izu Belloso, R M, Jaén Olasolo, P

“…A significant proportion of women of childbearing age have psoriasis. The aim of this study was to examine family planning concerns in this population…”
Get full text

Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas by Izu-Belloso, R, Gainza-Apraiz, I, Ortiz-Romero, P, Servitje-Bedate, O, Fernández de Misa-Cabrera, R, Peñate, Y, Hernandez-Machin, B, Estrach-Panella, T, Llamas-Velasco, M, Yanguas-Bayona, J I, Morillo-Andujar, M, Acebo-Mariñas, E, Perez-Gala, S, Armario-Hita, J C, Sanchez-Sambucety, P, Ortiz-Brugues, A, Eguren-Michelena, C, Bielsa-Marsol, I, Lopez-Pestaña, A, Blanes-Martinez, M, Fernandez-Guarino, M, Lopez-Lerma, I

“…Bexarotene has been approved to treat advanced stage cutaneous T-cell lymphomas (CTCL) since 1999. However, very few data have been published on its long-term…”
Get full text

Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas by Izu-Belloso, R., Gainza-Apraiz, I., Ortiz-Romero, P., Servitje-Bedate, O., Fernández de Misa-Cabrera, R., Peñate, Y., Hernandez-Machin, B., Estrach-Panella, T., Llamas-Velasco, M., Yanguas-Bayona, J.I., Morillo-Andujar, M., Acebo-Mariñas, E., Perez-Gala, S., Armario-Hita, J.C., Sanchez-Sambucety, P., Ortiz-Brugues, A., Eguren-Michelena, C., Bielsa-Marsol, I., Lopez-Pestaña, A., Blanes-Martinez, M., Fernandez-Guarino, M., Lopez-Lerma, I.

“…Bexarotene has been approved to treat advanced stage cutaneous T-cell lymphomas (CTCL) since 1999. However, very few data have been published on its long-term…”
Get full text

[Translated article] Family Planning Concerns Among Women With Psoriasis: A Descriptive, Cross-Sectional, Multicenter Study by Jiménez Gómez, N, González-Cantero, Á, Ruiz-Villaverde, R, Llamas-Velasco, M, de la Cueva Dobao, P, Rivera Díaz, R, Martínez Lorenzo, E, Alonso Pacheco, M L, Baniandrés Rodríguez, O, Mollet Sánchez, J, Pitarch Bort, G, Izu Belloso, R M, Jaén Olasolo, P

“…A significant proportion of women of childbearing age have psoriasis. The aim of this study was to examine family planning concerns in this population…”
Get full text

Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage by Navarro Matilla, B, Ortiz Romero, P L, Pujol Vallverdú, R M, Combalia Escudero, A, Zapata Paz, I, González Barca, E, Muniesa Montserrat, C, Morillo Andújar, M, Pérez Ferriols, A, Román Curto, C, Fernández de Misa Cabrera, R, Hospital Gil, M, Marín Niebla, A, Rios Rull, P J, de la Cruz Vicente, F, Izu Belloso, R M, Martín García-Sancho, A, Parera Amer, M E, Córdoba Mascuñano, R, Ramón Quiles, M D, Saus Carreres, A, Del Campo García, R, Machan, S, Viguera Ester, P, Blanco Garnelo, J

“…The cost of treating cutaneous T-cell lymphoma (CTCL) in Spain is unknown. With the advent of new treatments, it is more important than ever to gain an…”
Get full text

Treatment of Cutaneous Lymphomas: an Update by Izu-Belloso, R.M, García-Ruiz, J.C

“…Abstract Primary cutaneous lymphomas (PCLs) are a heterogeneous group of lymphoid tumors that originate primarily in the skin. Most PCLs (75%) are T-cell…”
Get full text

Translated article Real-World Clinical, Psychosocial and Financial Burden of Atopic Dermatitis: Results from the Spanish Cohort of the MEASURE-AD Trial by Silvestre, J F, Ruiz-Villaverde, R, Pérez-García, B, Herranz Pinto, P, Domínguez-Cruz, J J, Gentile, M, Izu Belloso, R M

“…Atopic dermatitis (AD) is one of the most prevalent skin diseases, but there are numerous knowledge gaps surrounding the impact this disease has on quality of…”
Get full text

Real-World clinical, psychosocial and financial burden of atopic dermatitis: results from the Spanish cohort of the MEASURE-AD trial by Silvestre, J F, Ruiz-Villaverde, R, Pérez-García, B, Herranz Pinto, P, Domínguez-Cruz, J J, Gentile, Maurizio, Izu Belloso, R M

“…Atopic dermatitis (AD) is one of the most prevalent skin diseases, but there are numerous knowledge gaps surrounding the impact this disease has on quality of…”
Get full text

Carga clínica, psicosocial y económica de la dermatitis atópica en vida real: resultados de la cohorte española del estudio MEASURE-AD by Silvestre, J F, Ruiz-Villaverde, R, Pérez-García, B, Herranz Pinto, P, Domínguez-Cruz, J J, Gentile, Maurizio, Izu Belloso, R M

“…Atopic dermatitis (AD) is one of the most prevalent skin diseases, but there are numerous knowledge gaps surrounding the impact this disease has on quality of…”
Get full text

[Translated article] Waxy Palms and Soles in an Adolescent Girl by Gainza Apraiz, I., Juliá Manresa, M., Izu Belloso, R.M.

Get full text

Condicionantes de acceso a nuevos medicamentos dermatológicos en España: resultados del proyecto EQUIDAD by M. Sánchez-Díaz, Á. Flórez, M. Ara-Martín, S. Arias-Santiago, R. Botella-Estrada, J. Cañueto, G. Carretero-Hernández, P. Coto-Segura, E. de Eusebio-Murillo, F.J. García-Latasa de Araníbar, V. García-Patos Briones, J. Gardeazabal García, C. Gómez-Fernández, S. Hernández-Ostiz, R. Izu Belloso, A. López-Ávila, P. Manchado López, A. Martín-Santiago, I. Martinez de Espronceda Ezquerro, A. Mateu-Puchades, P. Mercader-García, J. Notario Rosa, L. Palacio Aller, C. Pérez-Hortet, L. Quintana-Castanedo, R. Rivera, V. Rocamora Duran, I.M. Rodríguez-Nevado, R. Ruiz-Villaverde, J. Suárez, L. Trasobares-Marugán, C. Vizán-de Uña, I. Yanguas, A. Zulaica-Garate, I. García-Doval, M.Á. Descalzo, M. Grau-Pérez, J.M. Carrascosa-Carrillo

“…Resumen: Antecedentes: En España, aunque el Ministerio de Sanidad elabora el informe de posicionamiento terapéutico (IPT) y las condiciones de reembolso de los…”
Get full text

[Translated article] Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage by Navarro Matilla, B, Ortiz Romero, P L, Pujol Vallverdú, R M, Combalia Escudero, A, Zapata Paz, I, González Barca, E, Muniesa Montserrat, C, Morillo Andújar, M, Pérez Ferriols, A, Román Curto, C, Fernández de Misa Cabrera, R, Hospital Gil, M, Marín Niebla, A, Rios Rull, P J, de la Cruz Vicente, F, Izu Belloso, R M, Martín García-Sancho, A, Parera Amer, M E, Córdoba Mascuñano, R, Ramón Quiles, M D, Saus Carreres, A, Del Campo García, R, Machan, S, Viguera Ester, P, Blanco Garnelo, J

“…The cost of treating cutaneous T-cell lymphoma (CTCL) in Spain is unknown. With the advent of new treatments, it is more important than ever to gain an…”
Get full text

[Artículo traducido] Experiencia con bexaroteno en linfoma cutáneo de células T: un estudio del Grupo Español de Linfomas Cutáneos (GELC) by Izu-Belloso, R., Gainza-Apraiz, I., Ortiz-Romero, P., Servitje-Bedate, O., Fernández de Misa-Cabrera, R., Peñate, Y., Hernandez-Machin, B., Estrach-Panella, T., Llamas-Velasco, M., Yanguas-Bayona, J.I., Morillo-Andujar, M., Acebo-Mariñas, E., Perez-Gala, S., Armario-Hita, J.C., Sanchez-Sambucety, P., Ortiz-Brugues, A., Eguren-Michelena, C., Bielsa-Marsol, I., Lopez-Pestaña, A., Blanes-Martinez, M., Fernandez-Guarino, M., Lopez-Lerma, I.

“…El bexaroteno está aprobado para el tratamiento de linfomas cutáneos de células T (LCCT) en estadio avanzado desde 1999. Sin embargo, se han publicado muy…”
Get full text

Cutaneous Lymphoma in Actas Dermo-Sifiliográficas: A Historical Perspective by Izu Belloso, R.M.

“…This article reviews the history of cutaneous lymphomas through the articles published on this subject in the journal Actas Dermo-Sifiliográficas…”
Get full text

Condicionantes de acceso a nuevos medicamentos dermatológicos en España: resultados del proyecto EQUIDAD by Sánchez-Díaz, M., Flórez, Á., Ara-Martín, M., Arias-Santiago, S., Botella-Estrada, R., Cañueto, J., Carretero-Hernández, G., Coto-Segura, P., de Eusebio-Murillo, E., García-Latasa de Araníbar, F.J., García-Patos Briones, V., Gardeazabal García, J., Gómez-Fernández, C., Hernández-Ostiz, S., Izu Belloso, R., López-Ávila, A., Manchado López, P., Martín-Santiago, A., Martinez de Espronceda Ezquerro, I., Mateu-Puchades, A., Mercader-García, P., Notario Rosa, J., Palacio Aller, L., Pérez-Hortet, C., Quintana-Castanedo, L., Rivera, R., Rocamora Duran, V., Rodríguez-Nevado, I.M., Ruiz-Villaverde, R., Suárez, J., Trasobares-Marugán, L., Vizán-de Uña, C., Yanguas, I., Zulaica-Garate, A., García-Doval, I., Descalzo, M.Á., Grau-Pérez, M., Carrascosa-Carrillo, J.M.

“…[Display omitted] En España, aunque el Ministerio de Sanidad elabora el informe de posicionamiento terapéutico (IPT) y las condiciones de reembolso de los…”
Get full text

POSB48 Cost of Illness By Disease Stage of Patients with Mycosis Fungoides and Sézary Syndrome: A Real-World Analysis in Spanish Patients (Micados Study) by Navarro Matilla, B, Ortiz Romero, PL, Pujol Vallverdú, RM, Combalia Escudero, A, Zapata Paz, I, González Barca, E, Muniesa Montserrat, C, Morillo Andújar, M, Pérez Ferriols, A, Román Curto, C, Fernández de Misa Cabrera, R, Hospital Gil, M, Marín Niebla, A, Rios Rull, PJ, de la Cruz, F, Izu Belloso, RM, Martín García-Sancho, A, Parera Amer, ME, Córdoba, R, Ramón Quiles, MD, Saus Carreres, A, Del Campo García, R, Machan, S, Viguera Ester, P, Blanco Garnelo, J, Silva Romero, I, Soler López, B

Get full text

[Translated article] Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage by Navarro Matilla, B., Ortiz Romero, P.L., Pujol Vallverdú, R.M., Combalia Escudero, A., Zapata Paz, I., González Barca, E., Muniesa Montserrat, C., Morillo Andújar, M., Pérez Ferriols, A., Román Curto, C., Fernández de Misa Cabrera, R., Hospital Gil, M., Marín Niebla, A., Rios Rull, P.J., de la Cruz Vicente, F., Izu Belloso, R.M., Martín García-Sancho, A., Parera Amer, M.E., Córdoba Mascuñano, R., Ramón Quiles, M.D., Saus Carreres, A., del Campo García, R., Machan, S., Viguera Ester, P., Blanco Garnelo, J.

“…[Display omitted] The cost of treating cutaneous T-cell lymphoma (CTCL) in Spain is unknown. With the advent of new treatments, it is more important than ever…”
Get full text

Cost of early-stage mycosis fungoides treatments in Spain by Ortiz-Romero, Pablo Luis, Servitje, Octavio, Estrach, María Teresa, Izu-Belloso, Rosa María, Fernández-de-Misa, Ricardo, Gallardo, Fernando, López-Martínez, Noemí, Pérez-Mitru, Alejandro

“…To identify the most common therapeutic options for the treatment of early-stage mycosis fungoides in Spain, quantify their associated healthcare resource use…”
Get full text